eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | carcinoma, squamous cell |
| Comorbidity | C0022572|keratoacanthoma |
| Sentences | 6 |
| PubMedID- 22176864 | [the value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma]. |
| PubMedID- 25997466 | Eruptive squamous cell carcinomas with keratoacanthoma-like features in a patient treated with ruxolitinib. |
| PubMedID- 21369650 | Eruptive squamous cell carcinomas with keratoacanthoma-like features in a patient treated with sorafenib. |
| PubMedID- 22646803 | Dermokine-beta/gamma was expressed in keratoacanthoma and a part of well-differentiated squamous cell carcinoma (scc). |
| PubMedID- 25711204 | Results: hipk2 expression was distinct between preinvasive and invasive lesions: the expression decreased in keratoacanthoma (none of eight) and squamous cell carcinoma (five of 35) compared to actinic keratosis (12 of 19) and bowen's disease (10 of 23) (p < 0.001). |
| PubMedID- 25676557 | Our objective is to examine the relationship of keratoacanthoma with squamous cell carcinoma and normal skin by using dna microarrays. |
Page: 1